Luo Jian-Chang, Wang Luo-Dan, Xu Wen-Bin, Lang Bo-Xu
Department of Acupuncture-Moxibustion, Tuina and Rehabilitation, Taizhou Municipal Hospital, Taizhou 318000, Zhejiang Province, China.
Zhongguo Zhen Jiu. 2022 Aug 12;42(8):844-8. doi: 10.13703/j.0255-2930.20211015-0001.
To compare the effect of micro-needle knife therapy and betahistine mesilate tablets in the treatment of cervical vertigo (CV) and the influence on the mean blood flow velocity (Vm) of vertebral artery.
A total of 200 patients with CV were randomly divided into a micro-needle knife group (100 cases, 5 cases dropped off) and a medication group (100 cases, 3 cases dropped off). In the micro-needle knife group, micro-needle knife was performed on the suboccipital triangle of the atlantoaxial segment of the posterior neck, once every other day, for a total of 7-time treatment. The medication group received oral betahistine mesilate tablets, 6 mg each time, three times a day, for 14 consecutive days. The dizziness handicap inventory (DHI) scores of the two groups were observed before treatment, after treatment and during follow-up 3 months after treatment; the Vm of vertebral artery was compared between the two groups before and after treatment, and the clinical effect was evaluated during follow-up.
After treatment and during follow-up, the DHI scores of the two groups were lower than those before treatment (<0.001), and those in the micro-needle knife group were lower than the medication group (<0.001). After treatment, the Vm of bilateral vertebral arteries in both groups was higher than that before treatment (<0.05), and that in the micro-needle knife group was higher than the medication group (<0.05). The total effective rate of the micro-needle knife group was 96.8% (92/95), which was higher than 67.0% (65/97) of the medication group (<0.001).
Micro-needle knife therapy can improve vertigo symptoms and balance dysfunction, increase the mean blood flow velocity of vertebral artery in CV patients, and its clinical efficacy is better than oral betahistine mesilate tablets.
比较小针刀疗法与甲磺酸倍他司汀片治疗颈性眩晕（CV）的效果及对椎动脉平均血流速度（Vm）的影响。
将200例CV患者随机分为小针刀组（100例，脱落5例）和药物组（100例，脱落3例）。小针刀组于后颈部寰枢段枕下三角行小针刀治疗，隔日1次，共治疗7次。药物组口服甲磺酸倍他司汀片，每次6mg，每日3次，连续服用14天。观察两组治疗前、治疗后及治疗后3个月随访时的头晕残障量表（DHI）评分；比较两组治疗前后椎动脉Vm，并在随访期间评估临床疗效。
治疗后及随访期间，两组DHI评分均低于治疗前（<0.001），且小针刀组低于药物组（<0.001）。治疗后，两组双侧椎动脉Vm均高于治疗前（<0.05），且小针刀组高于药物组（<0.05）。小针刀组总有效率为96.8%（92/95），高于药物组的67.0%（65/97）（<0.001）。
小针刀疗法可改善CV患者的眩晕症状和平衡功能障碍，提高椎动脉平均血流速度，临床疗效优于口服甲磺酸倍他司汀片。
